Eli Lilly’s Open Letter on Mounjaro® and Zepbound® Practices

Lilly’s Commitment to Safe Use of Mounjaro® and Zepbound®

Lilly is dedicated to improving lives for people with diabetes and obesity through innovative medications like Mounjaro® and Zepbound®. Guided by our founder’s principle, “If it bears a red Lilly, it’s right,” we emphasize the safe and appropriate use of these drugs.

Key Points:

Inappropriate Use:

  • Cosmetic Use: Mounjaro® and Zepbound® are not approved for cosmetic weight loss.
  • Under 18: Not approved for individuals under 18.

Safety Concerns:

  • Only Mounjaro® and Zepbound® are FDA-approved tirzepatide medications.
  • Beware of unsafe online and social media ads, illegal online pharmacies, and misleading advertisements.
  • Only use these medications as prescribed by a licensed healthcare professional.

Non-Lilly Products:

  • Fake and unsafe products pose significant health risks.
  • Compounded versions of tirzepatide are not FDA-approved and may be dangerous.
  • Report any suspected counterfeit or unsafe products to local authorities or Lilly.

Identifying Genuine Products:

  • Ensure you know what authentic Mounjaro® or Zepbound® packaging looks like to avoid counterfeit medications.

Detailed Information:

Cosmetic Use: Mounjaro® and Zepbound® are for treating serious diseases and not for cosmetic weight loss. Lilly does not support off-label uses of these medications.

Pediatric Use: These medications are only approved for adults over 18. Promotions targeting younger audiences are inappropriate and unsafe.

Genuine Medication: Lilly is the only supplier of FDA-approved tirzepatide. Non-Lilly tirzepatide products, including those sold online or through unauthorized channels, are not safe.

Risks of Non-Lilly Products: Fake products may contain unsafe ingredients and are often sold through illegal online pharmacies or social media, posing significant health risks.

Safety of Compounded Medications: Compounded tirzepatide has not been evaluated by the FDA and may cause harm. Only use medications from verified sources.

Reporting Issues: Report any concerns about counterfeit or unsafe products to local law enforcement, state pharmacy boards, or the Lilly Answers Center.

For more information or concerns, contact Lilly at 1-800-LillyRx (1-800-545-5979). Always consult your healthcare provider before using Mounjaro® or Zepbound®.

Source Link

Newsletter Updates

Enter your email address below and subscribe to our newsletter